Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MOLINA HEALTHCARE, INC.MOH · Entity 3504 | Director | October 01, 2026 | October 03, 2026 |
| NRC HEALTHNRC · Entity 5534 | Director | June 23, 2026 | June 25, 2026 |
| WEST PHARMACEUTICAL SERVICES INCWST · Entity 3201 | Director | May 04, 2026 | May 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MOLINA HEALTHCARE, INC.
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,688 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 304 · Balance 4,688 F1: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares. F3: Represents the closing price of the Issuer's common stock on October 1, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
F2: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares.
F3: Represents the closing price of the Issuer's common stock on October 1, 2026.
NRC HEALTH
Report date June 23, 2026 · Filed June 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,697 |
Reported balance
After 2026-06-23 transaction · row 1
1 source rowRow 1 · 2026-06-23 · Grant · Acquired 7,697 · Balance 7,697 F1: This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions. |
Filing footnotes · ownership attribution and instrument terms
F1: This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions.
WEST PHARMACEUTICAL SERVICES INC
Report date May 04, 2026 · Filed May 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,523.2615 |
Reported balance
After 2026-05-04 transaction · row 1
1 source rowRow 1 · 2026-05-04 · Grant · Acquired 791 · Balance 3,523.2615 F1: These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 3, 2026 00:48 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 304 | $180.85 | $54,978.40 |
DisclosureSEC source: 0001856013-26-000008 · wk-form4_1790974131.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,688 F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares. F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2026. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 20:50 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 237 | $232.55 | $55,114.35 |
DisclosureSEC source: 0001856013-26-000006 · wk-form4_1783025437.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,384 F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2026. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 20:41 UTC | NRC HEALTH NRC · Entity 5534 | GrantCommon Stock | 7,697 | $0.00 | $0.00 |
DisclosureSEC source: 0001008886-26-000187 · form4.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,697 F1 · shares: This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions. F1 · acquired: This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions. Read SEC document |
| May 04, 2026 Filed May 6, 2026 21:33 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 791 | $0.00 | $0.00 |
DisclosureSEC source: 0000105770-26-000064 · form4.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,523.2615 F1 · shares: These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 20:48 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 405 | $135.82 | $55,007.10 |
DisclosureSEC source: 0001856013-26-000004 · wk-form4_1775162898.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,147 F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2026 was $135.82, which resulted in a grant of 405 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2026. Read SEC document |
| January 22, 2026 Filed Feb 18, 2026 00:21 UTC | NRC HEALTH NRC · Entity 5534 | GrantDirector Stock Option (Right to Buy) · Derivative | 8,819 | $0.00 Strike: $22.01 | $0.00 |
DisclosureSEC source: 0001008886-26-000041 · form4.xml · derivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,819 Underlying: Common Stock · 8,819 shares Expires 2036-01-22 F1 · security: This award is a grant to the reporting person made under the Issuer's 2025 Omnibus Incentive Plan for participating in two in-person meetings since the 2025 Annual Meeting of Stockholders. Read SEC document |
| January 01, 2026 Filed Jan 2, 2026 21:54 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 317 | $173.54 | $55,012.18 |
DisclosureSEC source: 0001856013-26-000002 · wk-form4_1767390888.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,742 F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2026, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2025, of $173.54. Thus, the grant this quarter for services as a Director is for 317 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2025. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 00:02 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 285 | $192.79 | $54,945.15 |
DisclosureSEC source: 0001856013-25-000003 · wk-form4_1759449736.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,425 F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2025 was $192.79, which resulted in a grant of 285 shares. F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2025. Read SEC document |
| July 01, 2025 Filed Jul 2, 2025 21:17 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 180 | $306.29 | $55,132.20 |
DisclosureSEC source: 0001179929-25-000107 · wk-form4_1751491054.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,140 F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2025 was $306.29, which resulted in a grant of 180 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2025. Read SEC document |
| May 07, 2025 Filed May 9, 2025 21:05 UTC | NRC HEALTH NRC · Entity 5534 | GrantDirector Stock Option (Right to Buy) · Derivative | 34,917 | $0.00 Strike: $13.09 | $0.00 |
DisclosureSEC source: 0001008886-25-000112 · form4.xml · derivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,917 Underlying: Common Stock · 34,917 shares Expires 2035-05-07 F1 · derivative.exercise_date: This award is an annual grant to the reporting person made under the Issuer's 2025 Omnibus Incentive Plan on the date of the Issuer's 2025 annual shareholder meeting. The award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to vesting, forfeiture, and termination provisions. Read SEC document |
| May 06, 2025 Filed May 8, 2025 20:28 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 1,071 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-013693 · form4.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,708.407 F1 · shares: These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 20:54 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 168 | $327.71 | $55,055.28 |
DisclosureSEC source: 0001179929-25-000059 · wk-form4_1743627235.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,960 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2025 was $327.71, which resulted in a grant of 168 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2025. Read SEC document |
| January 01, 2025 Filed Jan 2, 2025 22:21 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 189 | $291.05 | $55,008.45 |
DisclosureSEC source: 0001179929-25-000017 · wk-form4_1735856482.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,792 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2024. F2 · acquired: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2025, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2024, of $291.05. Thus, the grant this quarter for services as a Director is for 189 shares of the Issuer's common stock. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:44 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 161 | $341.91 | $55,047.51 |
DisclosureSEC source: 0001179929-24-000143 · wk-form4_1727901868.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,603 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2024, was $341.91, which resulted in a grant of 161 shares. F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2024. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 21:00 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 188 | $292.16 | $54,926.08 |
DisclosureSEC source: 0001179929-24-000117 · wk-form4_1719954049.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,442 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2024, was $292.16, which resulted in a grant of 188 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2024. Read SEC document |
| May 08, 2024 Filed May 10, 2024 20:10 UTC | NRC HEALTH NRC · Entity 5534 | GrantDirector Stock Option (Right to Buy) · Derivative | 10,906 | $0.00 Strike: $29.76 | $0.00 |
DisclosureSEC source: 0001008886-24-000148 · form4.xml · derivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,906 Underlying: Common Stock · 10,906 shares Expires 2034-05-08 F1 · derivative.exercise_date: This award is an annual grant to the reporting person made under the Issuer's 2004 Non-Employee Director Stock Plan (the "Plan") on the date of the Issuer's 2024 annual shareholder meeting. In accordance with the terms of the Plan, the award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to certain exceptions provided in the Plan. Read SEC document |
| April 23, 2024 Filed Apr 25, 2024 20:47 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 564 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-013405 · form4.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,634 F1 · shares: These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 21:01 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 136 | $404.20 | $54,971.20 |
DisclosureSEC source: 0001179929-24-000083 · wk-form4_1712091677.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,254 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2024, was $404.20, which resulted in a grant of 136 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2024. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 00:20 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 152 | $361.31 | $54,919.12 |
DisclosureSEC source: 0001179929-24-000019 · wk-form4_1704241217.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,118 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2024, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 29, 2023, of $361.31. Thus, the grant this quarter for services as a Director is for 152 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 29, 2023. Read SEC document |
| October 01, 2023 Filed Oct 2, 2023 23:28 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 168 | $327.89 | $55,085.52 |
DisclosureSEC source: 0001179929-23-000121 · wk-form4_1696289290.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,966 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of October 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on September 29, 2023, of $327.89. Thus, the grant this quarter for services as a Director is for 168 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on September 29, 2023. Read SEC document |
| July 01, 2023 Filed Jul 3, 2023 20:59 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 183 | $301.24 | $55,126.92 |
DisclosureSEC source: 0001179929-23-000088 · wk-form4_1688417968.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,798 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 30, 2023, of $301.24. Thus, the grant this quarter for services as a Director is for 183 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on June 30, 2023. Read SEC document |
| May 11, 2023 Filed May 15, 2023 21:52 UTC | NRC HEALTH NRC · Entity 5534 | GrantDirector Stock Option (Right to Buy) · Derivative | 7,386 | $0.00 Strike: $43.15 | $0.00 |
DisclosureSEC source: 0001008886-23-000069 · form4.xml · derivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,386 Underlying: Common Stock · 7,386 shares Expires 2033-05-11 F1 · derivative.exercise_date: This award is an annual grant to the reporting person made under the Issuer's 2004 Non-Employee Director Stock Plan (the "Plan") on the date of the Issuer's 2023 annual shareholder meeting. In accordance with the terms of the Plan, the award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to certain exceptions provided in the Plan. Read SEC document |
| April 25, 2023 Filed Apr 27, 2023 21:41 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 616 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-23-003706 · primarydocument.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,070 F1 · price: These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting. Read SEC document |
| April 01, 2023 Filed Apr 3, 2023 22:50 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 206 | $267.49 | $55,102.94 |
DisclosureSEC source: 0001179929-23-000063 · wf-form4_168056224174048.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,615 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of April 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on March 31, 2023, of $267.49. Thus, the grant this quarter for services as a Director is for 206 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on March 31, 2023. Read SEC document |
| January 01, 2023 Filed Jan 3, 2023 23:22 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 167 | $330.22 | $55,146.74 |
DisclosureSEC source: 0001179929-23-000014 · wf-form4_167278814773425.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,409 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 30, 2022, of $330.22. Thus, the grant this quarter for services as a Director is for 167 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 30, 2022. Read SEC document |
| October 01, 2022 Filed Oct 5, 2022 17:47 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 167 | $329.84 | $55,083.28 |
DisclosureSEC source: 0001179929-22-000161 · wf-form4_166499200989578.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,242 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of October 1, 2022 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on September 30, 2022, of $329.84. Thus, the grant this quarter for services as a Director is for 167 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on September 30, 2022 Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 17:25 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 454 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-22-005806 · primarydocument.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 454 F1 · price: These shares of restricted stock units will vest in full on the day of the 2023 Annual Shareholders Meeting. Read SEC document |
| July 01, 2022 Filed Jul 1, 2022 23:39 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 194 | $282.90 | $54,882.60 |
DisclosureSEC source: 0001179929-22-000102 · wf-form4_165671875734514.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,075 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2022, the first day of the quarter, was $282.90, which resulted in a grant of 194 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2022 Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:47 UTC | NRC HEALTH NRC · Entity 5534 | GrantDirector Stock Option (Right to Buy) · Derivative | 12,078 | $0.00 Strike: $32.46 | $0.00 |
DisclosureSEC source: 0001567619-22-011406 · doc1.xml · derivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,078 Underlying: Common Stock · 12,078 shares Expires 2032-05-18 F1 · derivative.exercise_date: This award is an annual grant to the reporting person made under the Issuer's 2004 Non-Employee Director Stock Plan (the "Plan") on the date of the Issuer's 2022 annual shareholder meeting. In accordance with the terms of the Plan, the award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to certain exceptions provided in the Plan. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 00:42 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 162 | $339.41 | $54,984.42 |
DisclosureSEC source: 0001179929-22-000074 · wf-form4_164911934556867.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 881 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2022, the first day of the quarter, was $339.41, which resulted in a grant of 162 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2022 Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 00:31 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 173 | $318.08 | $55,027.84 |
DisclosureSEC source: 0001179929-22-000016 · wf-form4_164125627416608.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 719 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2022 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2021, of $318.08. Thus, the grant this quarter for services as a Director is for 173 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2021. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 01:00 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 203 | $271.51 | $55,116.53 |
DisclosureSEC source: 0001179929-21-000156 · wf-form4_163339559122868.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 546 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2021, the first day of the quarter, was $271.51, which resulted in a grant of 203 shares. F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2021. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 21:09 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 215 | $256.05 | $55,050.75 |
DisclosureSEC source: 0001179929-21-000124 · wf-form4_162526013529397.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2021, the first day of the quarter, was $256.05, which resulted in a grant of 215 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2021. Read SEC document |
| June 29, 2021 Filed Jul 1, 2021 20:46 UTC | NRC HEALTH NRC · Entity 5534 | GrantDirector Stock Option (Right to Buy) · Derivative | 7,289 | $0.00 Strike: $46.32 | $0.00 |
DisclosureSEC source: 0001567619-21-012850 · doc1.xml · derivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,289 Underlying: Common Stock · 7,289 shares Expires 2031-06-29 F1 · derivative.exercise_date: This award is an annual grant to the reporting person made under the Issuer's 2004 Non-Employee Director Stock Plan (the "Plan") on the date of the Issuer's 2021 annual shareholder meeting. In accordance with the terms of the Plan, the award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to certain exceptions provided in the Plan. Read SEC document |
| May 18, 2021 Filed May 19, 2021 20:12 UTC | NRC HEALTH NRC · Entity 5534 | GrantDirector Stock Option (Right to Buy) · Derivative | 6,822 | $0.00 Strike: $48.97 | $0.00 |
DisclosureSEC source: 0001567619-21-010724 · doc1.xml · derivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,822 Underlying: Common Stock · 6,822 shares Expires 2031-05-18 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.